临床药师对一例肺神经内分泌癌化疗致痛风发作患者的药学监护

Clinical Pharmacists' Experience with Pharmaceutical Care for One Patient with Neuroendocrine Carcinoma of Lung Complicated by Chemotherapy-induced Gout Attack

目的:探讨临床药师对肺神经内分泌癌化疗诱发痛风发作患者提供药学监护的要点。方法:临床药师参与1例肺神经内分泌癌患者的药物治疗全过程,从化疗引起高尿酸血症的防治、痛风患者的饮食及用药教育等方面对患者进行个体化的药学监护。结果与结论:对于因肿瘤化疗引起的痛风发作,临床药师应及早从化疗方案预处理、高尿酸血症及痛风急性发作防治等方面进行密切监护,及时干预。临床药师应利用药学专业知识,协助医、护人员做好肿瘤化疗诱发痛风发作风险的防治工作,为患者提供个体化的药学监护。

OBJECTIVE： To explore the key points for clinical pharmacists to provide pharmaceutical care for patient with neuroendocrine carcinoma of lung complicated by chemotherapy-induced gout attack. METHODS： Clinical pharmacists participated in the treatment for one patient with pulmonary neuroendocrine carcinoma and provided individual pharmaceutical care for patient regarding the prevention and treatment of chemotherapy-induced hyperuricemia and education on diet and medication for patients with gout. RESULTS CONCLUSIONS： For tumor patients with chemotherapy-induced gout attack,clinical pharmacist should provide close monitoring and intervention from aspects of chemotherapy pretreatment,prevention and treatment of both hyperuricemia and acute gout attacks.Clinical pharmacists should use their knowledge of pharmacy to assist medical staff in the prevention and treatment ofhyperuricemia and gout attack and offer individualized pharmaceutical care for patients.